Search

Your search keyword '"Lake JE"' showing total 135 results

Search Constraints

Start Over You searched for: Author "Lake JE" Remove constraint Author: "Lake JE" Topic hiv infections Remove constraint Topic: hiv infections
135 results on '"Lake JE"'

Search Results

1. MASLD in persons with HIV is associated with high cardiometabolic risk as evidenced by altered advanced lipoprotein profiles and targeted metabolomics.

2. Relationships Between Hepatic Steatosis and Frailty Differ by HIV Serostatus.

3. Incident Proteinuria by HIV Serostatus Among Men With Pre--Diabetes Mellitus: The Multicenter AIDS Cohort Study.

4. Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease.

5. Associations between epicardial, visceral, and subcutaneous adipose tissue with diastolic function in men with and without HIV.

7. Muscle Quality and Physical Function in Men With and Without HIV.

8. Effects of Food Insecurity on Hepatic Steatosis and Fibrosis in People With HIV.

9. A data-driven approach to implementing the HPTN 094 complex intervention INTEGRA in local communities.

10. The Effect of Open-Label Semaglutide on Metabolic Dysfunction-Associated Steatotic Liver Disease in People With HIV.

11. Microfluidic Isolation of Neuronal-Enriched Extracellular Vesicles Shows Distinct and Common Neurological Proteins in Long COVID, HIV Infection and Alzheimer's Disease.

12. Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV.

13. Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States.

14. Proprotein convertase subtisilin/kexin 9 levels decline with hepatitis C virus therapy in people with HIV/hepatitis C virus and correlate with inflammation.

15. Sexual network characteristics and partnership types among men who have sex with men diagnosed with syphilis, gonorrhoea and/or chlamydia in Lima, Peru.

16. Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease.

17. Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study).

18. Pharmacogenetics of weight gain following switch from efavirenz- to integrase inhibitor-containing regimens.

19. Energy balance and body composition after switch between integrase strand transfer inhibitors and doravirine among people with HIV.

20. Obesity Modifies the Relationship Between Raltegravir and Dolutegravir Hair Concentrations and Body Weight Gain in Women Living with HIV.

21. Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV.

22. Gender-affirming hormone therapy decreases d-dimer but worsens insulin sensitivity in transgender women.

23. The Impact of COVID-19 on HIV Care in Rio de Janeiro, Brazil 2019-2021: Disparities by Age and Gender.

24. Aging-Related Comorbidity Burden Among Women and Men With or At-Risk for HIV in the US, 2008-2019.

25. Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study.

26. Reproductive health syndemics impact retention in care among women living with HIV in Rio de Janeiro, Brazil.

27. Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus.

28. Social Networks Play a Complex Role in HIV Prevention Knowledge, Attitudes, Practices, and the Uptake of PrEP Through Transgender Women Communities Centered Around Three "Casas Trans" in Lima, Peru: A Qualitative Study.

29. Contribution of integrase inhibitor use, body mass index, physical activity and caloric intake to weight gain in people living with HIV.

30. Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus.

31. Ectopic Fat and Cardiac Health in People with HIV: Serious as a Heart Attack.

32. Estrogen May Enhance Toll-Like Receptor 4-Induced Inflammatory Pathways in People With HIV: Implications for Transgender Women on Hormone Therapy.

33. Anal cytology screening in men who have sex with men with HIV at a university hospital in Bogotá, Colombia.

34. Heightened levels of plasma growth differentiation factor 15 in men living with HIV.

35. Diabetes mellitus is associated with declines in physical function among men with and without HIV.

36. Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus.

37. Differences in Muscle Quantity and Quality by HIV Serostatus and Sex.

38. Poorer Muscle Quality and Quantity With ART Initiation Is Associated With Greater Inflammation and Immune Activation.

39. Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV and Aging Workshop.

40. Pre-exposure prophylaxis awareness, use, and intention to use in a regional sample of Latin American geosocial networking application users in 2018-2019.

41. Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials.

42. Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada.

43. PrEP Awareness, Use, Intention to Use, and Information Source Among Geosocial Networking Application Users in Mexico in 2018-2019.

44. Longitudinal Changes in Sex Hormone-Binding Globulin in Men With HIV.

45. Risk for incident diabetes is greater in prediabetic men with HIV than without HIV.

46. Tesamorelin improves fat quality independent of changes in fat quantity.

47. Let's Talk About Sex: The Impact of Partnership Contexts on Communication About HIV Serostatus and Condom Use Among Men Who Have Sex with Men (MSM) and Transgender Women (TW) in Lima, Peru.

48. Sexual health norms and communication patterns within the close social networks of men who have sex with men and transgender women in Lima, Peru: a 2017 cross-sectional study.

49. Impact of Integrase inhibitors and tenofovir alafenamide on weight gain in people with HIV.

50. Brief Report: HIV-1 Seroconversion Is Not Associated With Prolonged Rectal Mucosal Inflammation.

Catalog

Books, media, physical & digital resources